WuXi AppTec (OTCMKTS:WUXAY) Reaches New 1-Year High – Time to Buy?

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $18.59 and last traded at $18.59, with a volume of 206 shares traded. The stock had previously closed at $17.91.

Analyst Ratings Changes

Separately, Zacks Research raised shares of WuXi AppTec to a “hold” rating in a research report on Monday, April 13th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, WuXi AppTec presently has a consensus rating of “Moderate Buy”.

WuXi AppTec Stock Up 3.8%

The stock has a 50-day simple moving average of $16.45 and a 200 day simple moving average of $15.07.

WuXi AppTec (OTCMKTS:WUXAY) last issued its earnings results on Monday, April 27th. The company reported $0.23 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $0.05. The firm had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.59 billion.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.